Effects of the A(-115)G variant on CREB1 promoter activity in two brain cell lines: Interactions with gonadal steroids

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 8, 2010, Pages 1365-1372

  Zubenko, George S ^a,b   Hughes, Hugh B ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Carnegie Mellon University   (United States)

Author keywords

C6 glial and CATH.a neuronal cell lines; Depression; Genetics; Mood; Sex

Indexed keywords

ESTRADIOL; SEX HORMONE;

ALLELE; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN CELL; CONTROLLED STUDY; CREB1 GENE; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC VARIABILITY; GLIA CELL; LINKAGE ANALYSIS; MAJOR DEPRESSION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE;

ANIMALS; BRAIN; CELL LINE, TUMOR; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DEPRESSIVE DISORDER, MAJOR; ESTRADIOL; FEMALE; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GONADAL STEROID HORMONES; HUMANS; MICE; NEURONS; PROGESTERONE; PROMOTER REGIONS, GENETIC; TESTOSTERONE; TRANSFECTION;

EID: 78851470886     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31133     Document Type: Article

References (43)

1. Bhat RV, Budd Haeberlein SL, Avila J. 2004. Glycogen synthase kinase 3: A drug target for CNS therapies. J Neurochem 89(6): 1313-1317.
2. Carlezon WA Jr, Duman RS, Nestler EJ. 2005. The many faces of CREB. Trends Neurosci 28(8): 436-445.
3. Cornil CA, Ball GF, Balthazart J. 2006. Functional significance of the rapid regulation of brain estrogen action: Where do the estrogens come from? Brain Res 1126: 2-26.
4. Coven E, Ni Y, Widnell KI, Chen J, Walker WH, Habener JF, Nestler EJ. 1998. Cell type-specific regulation of CREB gene expression: Mutational analysis of CREB promoter activity. J Neurochem 71(5): 1865-1874.
5. Delfino FJ, Walker WH. 1999. NF-κB induces cAMP-response element-binding protein gene transcription in Sertoli cells. J Biol Chem 274: 35607-35613.
6. Harro J, Oreland L. 2001. Depression as a spreading adjustment disorder of monoaminergic neurons: A case for primary implication of the locus coeruleus. Brain Res Rev 38: 79-128.
7. Jope RS, Yuskaitis CJ, Beurel E. 2007. Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics. Neurochem Res 32(4-5): 577-595.
8. Lambert J-C, Goumidi L, Wavrant-De Vrieze F, Frigard B, Harris JM, Cummings A, Coates J, Pasquier F, Cottel D, Gaillac M, St. Clair D, Mann DMA, Hardy J, Lendon CL, Amouyel P, Chartier-Harlin M-C. 2000. The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum Mol Genet 9: 2275-2280.
9. Lau KF, Miller CC, Anderton BH, Shaw PC. 1999. Molecular cloning and characterization of the human glycogen synthase kinase-3beta promoter. Genomics 60(2): 121-128.
10. Lazennec G, Thomas JA, Katznellenbogen BS. 2001. Involvement of cyclic AMP response element binding protein (CREB) and estrogen receptor phosphorylation in the synergistic activation of the estrogen receptor by estradiol and protein kinase activators. J Steroid Biochem Mol Biol 77: 193-203.
11. Maher BS, Marazita ML, Zubenko WN, Spiker DG, Giles DE, Kaplan BB, Zubenko GS. 2002. Genetic segregation analysis of recurrent, early-onset major depression: Evidence for single major locus transmission. Am J Med Genet Part B 114B(2): 214-221.
12. Maher BS, Hughes HB III, Zubenko WN, Zubenko GS. 2009. Genetic linkage of region containing the CREB1 gene to depressive disorders in families with recurrent, early-onset, major depression: A re-analysis and confirmation of sex-specific effect. Am J Med Genet Part B 153B: 10-16.
13. Manji HK, Drevets WC, Charney DS. 2001. The cellular neurobiology of depression. Nat Med 7(5): 541-547.
14. Mayr B, Montminy M. 2001. Transcriptional regulation by the phosphorylation-dependent factor Creb. Nat Rev Mol Cell Biol 2: 599-609.
15. McEwen BS. 2001. Estrogens effects on the brain: Multiple sites and molecular mechanisms. J Appl Physiol 91: 2785-2801.
16. McEwen BS, Alves SE. 1999. Estrogen actions in the central nervous system. Endocr Rev 20(3): 279-307.
17. Meyer TE, Waeber G, Lin J, Beckmann W, Habener JF. 1993. The promoter of the gene encoding 3', 5'-cyclic adenosine monophosphate (cAMP) response element binding protein contains cAMP response elements: Evidence for positive autoregulation of gene transcription. Endocrinology 132: 770-780.
18. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. 2002. Neurobiology of depression. Neuron 34: 13-25.
19. Öngür D, Drevets WC, Price JL. 1998. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 95: 13290-13295.
20. Perlis RH, Purcell S, Fagerness J, Cusin C, Yamaki L, Fava M, Smoller JW. 2007a. Clinical and genetic dissection of anger expression and CREB1 polymorphisms in major depressive disorder. Biol Psychiatry 62: 536-540.
21. Perlis RH, Purcell S, Fava M, Fagerness J, Rush AJ, Trivedi MH, Smoller JW. 2007b. Association between treatment-emergent suicidal ideation with citalipram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D Study. Arch Gen Psychiatry 64: 689-697.
22. Philibert R, Caspers K, Langbehn D, Troughton EP, Yucuis R, Sandhu HK, Cadoret RJ. 2003. The association of the D2S2944 124bp allele with recurrent early onset major depressive disorder in women. Am J Med Genet Part B 121B(1): 39-43.
23. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, Overholser JC, Roth BL, Stockmeier CA. 1999. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 45: 1085-1098.
24. Ressler KJ, Nemeroff CB. 1999. Role of norepinephrine in the pathophysiology and treatment of mood disorders. Biol Psychiatry 46: 1219-1233.
25. Rose MD, Fink GR. 1987. KAR1, a gene required for function of both intranuclear and extranuclear microtubules in yeast. Cell 48: 1047-1060.
26. Schahab S, Heun R, Schmitz S, Maier W, Kölsch H. 2006. Association of polymorphism in the transcription factor LBP-1c/CP2/LSF gene with Alzheimer's disease and major depression. Dement Geriatr Cogn Disord 22: 95-98.
27. Selkoe DJ, Podlisny MB. 2002. Deciphering the genetic basis of Alzheimer's disease. Ann Rev Genomics Hum Genet 3: 67-99.
28. Shell SA, Fix C, Olejniczak D, Gram-Humphrey N, Walker WH. 2002. Regulation of cyclic adenosine 3', 5'-monophosphate response element binding protein (CREB) expression by Sp1 in the mammalian testes. Biol Reprod 66: 659-666.
29. Suri C, Fung BP, Tischler AS, Chikaraishi DM. 1993. Catecholaminergic cell lines from the brain and adrenal glands of tyrosine hydroxylase-SV40 T antigen transgenic mice. J Neurosci 13: 1280-1291.
30. Tremblay A, Giguere V. 2001. Contribution of steroid receptor co-activator-1 and CREB binding protein in ligand-independent activity of estrogen receptor beta. J Steroid Biochem Mol Biol 77: 19-27.
31. Walker WH, Fucci L, Habener JF. 1995. Expression of the gene encoding transcription factor cyclic adenosine 3', 5'-monophosphate (cAMP) response element binding protein (CREB): Regulation by follicle-stimulating hormone-induced cAMP signaling in primary rat Sertoli cells. Endocrinology 136: 3534-3545.
32. Weeber EJ, Sweatt JD. 2002. Molecular biology of human cognition. Neuron 33: 845-848.
33. Widnell KI, Russell DS, Nestler EJ. 1994. Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro. Proc Natl Acad Sci USA 91: 10947-10951.
34. Widnell KI, Chen J-S, Iredale PA, Walker WH, Duman RS, Habener JF, Nestler EJ. 1996. Transcriptional regulation of CREB (cyclic AMP response element-binding protein) expression in CATH.a cells. J Neurochem 66(4): 1770-1773.
35. Zubenko GS. 2000. Do susceptibility loci contribute to the expression of more than one mental disorder? A view from the genetics of Alzheimer's disease. Mol Psychiatry 5: 131-136.
36. Zubenko GS, Hughes HB III. 2008. Effects of the G(-656)A variant on CREB1 promoter activity in a glial cell line: Interactions with gonadal steroids and stress. Am J Med Genet Part B 147B: 579-585.
37. Zubenko GS, Hughes HB III. 2009. Effects of the G(-656)A variant on CREB1 promoter activity in a neuronal cell line: Interactions with gonadal steroids and stress. Mol Psychiatry 14: 390-397.
38. Zubenko GS, Zubenko WN, Spiker DG, Giles DE, Kaplan BB. 2001. The malignancy of recurrent, early-onset major depression: A family study. Am J Med Genet Part B 105B(8): 690-699.
39. Zubenko GS, Hughes HB III, Maher BS, Stiffler JS, Zubenko WN, Marazita ML. 2002a. Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression. Am J Med Genet Part B 114B: 980-987.
40. Zubenko GS, Hughes HB, Stiffler JS, Zubenko WN, Kaplan BB. 2002b. D2S2944 identifies a likely susceptibility locus for recurrent, early-onset, major depression in women. Mol Psychiatry 7(5): 460-467.
41. Zubenko GS, Hughes HB, Stiffler JS, Zubenko WN, Kaplan BB. 2002c. Genome survey for susceptibility loci for recurrent, early-onset major depression: Results at 10cM resolution. Am J Med Genet Part B 114B: 413-422.
42. Zubenko GS, Hughes HB III, Stiffler JS, Brechbiel A, Zubenko WN, Maher B, Marizita ML. 2003a. Sequence variations in CREB1 cosegregate with depressive disorders in women. Mol Psychiatry 8: 611-618.
43. Zubenko GS, Maher BS, Hughes HB III, Zubenko WN, Stiffler JS, Kaplan BB, Marazita ML. 2003b. Genome-wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent, early-onset, major depression. Am J Med Genet Part B 123B: 1-18.